Biallelic PDX1 (insulin promoter factor 1) mutations causing neonatal diabetes without exocrine pancreatic insufficiency
Open Access
- 16 January 2013
- journal article
- research article
- Published by Wiley in Diabetic Medicine
- Vol. 30 (5) , e197-e200
Abstract
Aims: Recessive PDX1 (IPF1) mutations are a rare cause of pancreatic agenesis, with three cases reported worldwide. A recent report described two cousins with a homozygous hypomorphic PDX1 mutation causing permanent neonatal diabetes with subclinical exocrine insufficiency. The aim of our study was to investigate the possibility of hypomorphic PDX1 mutations in a large cohort of patients with permanent neonatal diabetes and no reported pancreatic hypoplasia or exocrine insufficiency.Methods: PDX1 was sequenced in 103 probands with isolated permanent neonatal diabetes in whom ABCC8, KCNJ11 and INS mutations had been excluded.Results: Sequencing analysis identified biallelic PDX1 mutations in three of the 103 probands with permanent neonatal diabetes (2.9%). One proband and his affected brother were compound heterozygotes for a frameshift and a novel missense mutation (p.A34fsX191; c.98dupC and p.P87L; c.260C>T). The other two probands were homozygous for novel PDX1 missense mutations (p.A152G; c.455C>G and p.R176Q; c.527G>A). Both mutations affect highly conserved residues located within the homeobox domain. None of the four cases showed any evidence of exocrine pancreatic insufficiency, either clinically, or, where data were available, biochemically. In addition a heterozygous nonsense mutation (p.C18X; c.54C>A) was identified in a fourth case.Conclusions: This study demonstrates that recessive PDX1 mutations are a rare but important cause of isolated permanent neonatal diabetes in patients without pancreatic hypoplasia/agenesis. Inclusion of the PDX1 gene in mutation screening for permanent neonatal diabetes is recommended as a genetic diagnosis reveals the mode of inheritance, allows accurate estimation of recurrence risks and confirms the requirement for insulin treatment.Keywords
This publication has 11 references indexed in Scilit:
- GATA6 haploinsufficiency causes pancreatic agenesis in humansNature Genetics, 2011
- Sequencing PDX1 (insulin promoter factor 1) in 1788 UK individuals found 5% had a low frequency coding variant, but these variants are not associated with Type 2 diabetesDiabetic Medicine, 2011
- Permanent neonatal diabetes due to activating mutations in ABCC8 and KCNJ11Reviews in Endocrine and Metabolic Disorders, 2010
- A Novel Hypomorphic PDX1 Mutation Responsible for Permanent Neonatal Diabetes With Subclinical Exocrine DeficiencyDiabetes, 2009
- Neonatal diabetes mellitus with pancreatic agenesis in an infant with homozygous IPF-1 Pro63fsX60 mutationPediatric Diabetes, 2009
- Referral rates for diagnostic testing support an incidence of permanent neonatal diabetes in three European countries of at least 1 in 260,000 live birthsDiabetologia, 2009
- Mutations in PTF1A cause pancreatic and cerebellar agenesisNature Genetics, 2004
- Development of diabetes mellitus in aging transgenic mice following suppression of pancreatic homeoprotein IDX-1Journal of Clinical Investigation, 2001
- Development of diabetes mellitus in aging transgenic mice following suppression of pancreatic homeoprotein IDX-1Journal of Clinical Investigation, 2001
- Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequenceNature Genetics, 1997